ReShape Lifesciences Inc.
ReShape Lifesciences Inc. (RSLS) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 211 transactions totaling $16.8M, demonstrating a bearish sentiment with -$15.4M in net insider flow. The most recent transaction on May 31, 2024 involved a sale of 48 shares valued at $12.
RSLS Insider Activity Summary
Who Is Buying RSLS Stock?
No significant insider buying has been recorded for RSLS in the recent period.
Who Is Selling RSLS Stock?
No significant insider selling has been recorded for RSLS in the recent period.
Is ReShape Lifesciences Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RSLS is bearish with an Insider Alignment Score of 4/100 and a net flow of -$15.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RSLS Frequently Asked Questions
Understanding RSLS Insider Activity
Insider trading at ReShape Lifesciences Inc. (RSLS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading RSLS stock, having executed 211 transactions in the past 90 days. The most active insider is Steven Boyd (Executive), who has made 66 transactions totaling $14.6M.
Related Tools
Track ReShape Lifesciences Inc. Insider Activity
Get notified when executives and directors at RSLS file new Form 4 transactions